Yixintang Pharmaceutical (SZ:002727) 证券时报·2025-11-07 04:32Core Viewpoint - The article discusses the planned share transfer by the controlling shareholder of Yixin Tang (One Heart Hall),阮鸿献, to his daughters, which is part of a family asset planning strategy [5]. Group 1: Share Transfer Details - Yixin Tang announced that阮鸿献 plans to transfer up to 5.856 million shares (1% of total share capital) to阮圣翔 and阮爱翔, with a total transfer not exceeding 11.7121 million shares (2% of total share capital) [3][4]. - The estimated market value of the 5.856 million shares is approximately 78.6461 million yuan, while the total value of the shares to be transferred is about 157 million yuan [4]. Group 2: Background of the Controlling Shareholder -阮鸿献 has been the controlling shareholder since the company's listing in July 2014, and he currently holds 182 million shares, accounting for 31.74% of the total share capital [6]. -阮鸿献 and刘琼, the former co-controlling shareholder, divorced in January 2017, but their shareholding remained unchanged post-divorce [6]. Group 3: Profiles of Share Recipients -阮爱翔, born in September 1997, has been appointed as the vice president of Yixin Tang and has previously served as the assistant to the chairman [6]. -阮圣翔, born in January 1992, is involved in various leadership roles, including being the chairman of the Yunnan Shengai Traditional Chinese Medicine Foundation [7].